Invesco Ltd. Embecta Corp. Transaction History

Invesco Ltd.

$516 Billion
Q4 2024

A detailed history of Invesco Ltd. transactions in Embecta Corp. stock. As of the latest transaction made, Invesco Ltd. holds 416,674 shares of EMBC stock, worth $6.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

416,674

Previous 426,140 2.22%

Holding current value

$6.43 Million

Previous $6.01 Million 44.04%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$12.51 - $20.83 $118,419 - $197,176	-9,466 Reduced 2.22%	416,674 $8.65 Million
Q3 2024 Nov 12, 2024	SELL	$11.46 - $16.56 $1.16 Million - $1.68 Million	-101,313 Reduced 19.21%	426,140 $6.01 Million
Q2 2024 Aug 13, 2024	BUY	$10.13 - $14.6 $781,347 - $1.13 Million	77,132 Added 17.13%	527,453 $6.59 Million
Q1 2024 May 14, 2024	BUY	$12.35 - $19.33 $885,396 - $1.39 Million	71,692 Added 18.93%	450,321 $5.98 Million
Q4 2023 Feb 12, 2024	SELL	$12.87 - $19.09 $716,627 - $1.06 Million	-55,682 Reduced 12.82%	378,629 $7.17 Million
Q3 2023 Nov 13, 2023	SELL	$15.0 - $22.17 $115,650 - $170,930	-7,710 Reduced 1.74%	434,311 $6.54 Million
Q2 2023 Aug 11, 2023	BUY	$21.6 - $30.69 $101,498 - $144,212	4,699 Added 1.07%	442,021 $9.55 Million
Q1 2023 May 12, 2023	BUY	$23.07 - $32.77 $1.28 Million - $1.82 Million	55,487 Added 14.53%	437,322 $12.3 Million
Q4 2022 Feb 13, 2023	BUY	$25.29 - $35.48 $1.32 Million - $1.86 Million	52,348 Added 15.89%	381,835 $9.66 Million
Q3 2022 Nov 14, 2022	SELL	$24.0 - $33.42 $233,808 - $325,577	-9,742 Reduced 2.87%	329,487 $9.49 Million
Q2 2022 Aug 15, 2022	BUY	$24.78 - $33.36 $8.41 Million - $11.3 Million	339,229 New	339,229 $8.59 Million

Others Institutions Holding EMBC

# of Institutions

404

Shares Held

52.4M

Call Options Held

120K

Put Options Held

66.8K

View Full List

About Embecta Corp.

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $892M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

More about EMBC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account